Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases

Clinical trial NCT04899908 · RECRUITING

Trial details

NCT number: NCT04899908
Sponsor: Brigham and Women's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Brain Cancer Brain Metastases Melanoma Lung Cancer Breast Cancer HER2-positive Breast Cancer Colorectal Cancer Gastrointestinal Cancer SRS SRT Whole Brain Radiation Stereotactic Radiation

Start date: 2021-09-15
Primary completion: 2028-04-01
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.